Successful vemurafenib salvage treatment in a patient with primary refractory hairy cell leukemia and pulmonary aspergillosis

Ann Hematol. 2014 Aug;93(8):1439-40. doi: 10.1007/s00277-013-1987-7. Epub 2013 Dec 14.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Anti-Infective Agents / therapeutic use
  • Antineoplastic Agents / pharmacology
  • Antineoplastic Agents / therapeutic use*
  • Humans
  • Indoles / pharmacology
  • Indoles / therapeutic use*
  • Invasive Pulmonary Aspergillosis / drug therapy
  • Invasive Pulmonary Aspergillosis / etiology*
  • Invasive Pulmonary Aspergillosis / therapy
  • Leukemia, Hairy Cell / complications
  • Leukemia, Hairy Cell / drug therapy*
  • Male
  • Middle Aged
  • Molecular Targeted Therapy
  • Neoplasm Proteins / antagonists & inhibitors
  • Protein Kinase Inhibitors / pharmacology
  • Protein Kinase Inhibitors / therapeutic use*
  • Proto-Oncogene Proteins B-raf / antagonists & inhibitors
  • Remission Induction
  • Respiration, Artificial
  • Salvage Therapy*
  • Sulfonamides / pharmacology
  • Sulfonamides / therapeutic use*
  • Vemurafenib

Substances

  • Anti-Infective Agents
  • Antineoplastic Agents
  • Indoles
  • Neoplasm Proteins
  • Protein Kinase Inhibitors
  • Sulfonamides
  • Vemurafenib
  • BRAF protein, human
  • Proto-Oncogene Proteins B-raf